AngioChem
Carrier to cross the blood brain barrier (BBB)
Université du Québec à Montréal
ISR
- Intelligent Software Radio
High throughput programmable microwave radios
École de technologie supérieure
YD3
Harness with sensors for dynamic 3D measurement of
knee characteristics for diagnostic purposes
École de technologie supérieure
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
AngioChem Inc.
141 President Kennedy, suite SB-5210
Montreal, Quebec H2X 3Y7
Web Address : www.angiochem.com
President and CEO : Jean-Paul Castaigne, M.D.
Telephone : (514) 788-7800
Fax : (514) 788-7801
Email : jpcastaigne@angiochem.com
Angiochem, a biotechnology company, has the potential to become
a leader in the field of Central Nervous System (CNS) disorders
following the development of a technology platform allowing the
delivery of drugs to the brain without breaking the integrity of
the Blood-Brain Barrier. Short term, the company is developing innovative
drugs to treat brain tumours but it is already anticipating addressing
some numerous unmet medical needs for other diseases of the CNS.
AngioChem is a development company that will commercialize eventually
its own products. The company will finance its activities through
risk capital funding but also through the licensing of its technologies
to strategic partners in non-core areas.
Governmental and para-governmental agencies to fund its research
activities. Currently in negotiations with VC’s.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ISR Technologies Inc.
1100 Notre-Dame West
Montreal, Quebec H3C 1K3
Web Address : www.isr-technologies.com
President and CEO : Naïm Batani
Telephone : (514) 396-8873
Fax : (514) 396-8684
Email : nbatani@isr-technologies.com
Revenue (2005) : Cdn$ 1.5M (Estimate)
Market : US$ 1.5B
ISR provides a complete Software Defined Radio (SDR) modem allowing
microwave network operators to quadruple their capacity for 40 to
70% less cost than alternative hardware or mixed hardware/software
products. The technology flexibility allows ISR to aim at the following
markets :
- Cellular Backhaul cummunications, VoIP and high speed internet,
- Military communications,
- WiMax Communications (802.16) and
- Satellite communications,
- Maritime « Ship to Shore » communications.
ISR provides equipment suppliers a reference design for the modem
hardware and associated components. ISR will also provide all the
software/firmware that will be loaded into the radio. ISR will charge
a onetime fee for the reference design and a license fee for the
software/firmware loaded into each radio. Technical Support is provided
by ISR on a 7/24 basis for an annual charge.
Ultra Electronics and Xilinx Inc.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Solution YD3 Inc.
2099, Alexandre-de-Sève, 1st floor
Montréal, Québec
H2L 2W5
President and CEO : Jean-Pierre Langlois
Telephone : (514) 945-5169
Email : jp.langlois@videotron.ca
Revenue (estimates) : $75 000 (2004), $750 000 (2005), $4.5M (2006)
Market : $750M / year
The newly created company is a joint venture between Valeo, Univalor,
and Créa. Working for Solution YD3 are Jacques A. de Guise
of the École de Technologie Supérieure, L’Hocine
Yahia of École Polytechnique, and Nicolas Duval of the Centre
Hospitalier de L’Université de Montréal who
are inventors of technologies currently being exploited by Solution
YD3.
Solution YD3 provides a medical device for measuring dynamically
in 3D the characteristics of a knee. This device is used in telemedicine
and provides knee evaluation services for physiotherapists, orthopaedic
surgeons, and doctors specialised in sports medicine, physiatric,
and geriatric.
This innovative evaluation service fulfills the needs of specialised
clinics, professional sport teams and sport amateurs, hospitals,
and workman trades involved in high knee joint injuries risks. The
system is being evaluated in several clinics.
Clinique Physio+, Pavillon de Chamille, Université de Montréal,
Proscan, Wellness centers

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
|